Bone Tumor Clinical Trial
Official title:
Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors
Percutaneous vertebroplasty is a new technique to strengthen bone and reduce pain for patients with vertebral tumors
Destructive vertebral lesions are a common in metastatic disease, multiple myeloma and lymphoma. Symptoms are caused by pathologic fracture consequences secondary to vertebral destruction, development of spinal instability and compression of adjacent neurological elements. Nonoperative treatments include radiotherapy, hormone therapy, cytotoxic drugs which are effective to halt the osteolytic process and reverse the neurological compromise, however; they cannot provide stability or relieve pain or cord compression. Surgical management options including vertebrectomy, reconstruction with a cage or PMMA bone cement, and stabilization with pedicle screws can restore spinal canal support and neurological functions also control pain, however; usually associated with high postoperative morbidity and mortality. Also not advisable for multifocal spinal disease. Percutaneous vertebroplasty is a new technique to strengthen bone and reduce pain. It is percutaneous, minimally invasive, image-guided procedure that involves injection of radio-opaque bone cement into a partially collapsed vertebral body, in an effort to provide stability and pain relief. The exact mechanism of pain relief remains unclear. Proposed theories include more favourable biomechanics after cement strengthening, chemical toxicity and exothermic effect of cement polymerization on nerve endings. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05515068 -
Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
|
||
| Completed |
NCT02862288 -
Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT01679691 -
The Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Post Lower Limb Salvage Surgery
|
N/A | |
| Recruiting |
NCT04178044 -
Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection
|
Phase 1 | |
| Completed |
NCT03389724 -
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
|
Phase 3 | |
| Completed |
NCT05075889 -
Utility of ICG in Benign Bone Tumors
|
Early Phase 1 | |
| Recruiting |
NCT04755140 -
Endoprosthesis Metal Toxicity Study
|
||
| Completed |
NCT04798326 -
Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults
|
Phase 1 | |
| Active, not recruiting |
NCT04104750 -
The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
|
||
| Completed |
NCT00598741 -
Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors
|
N/A | |
| Completed |
NCT02398058 -
Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)
|
Phase 1 | |
| Recruiting |
NCT06171282 -
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
|
Early Phase 1 | |
| Not yet recruiting |
NCT06376682 -
EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy
|
N/A | |
| Enrolling by invitation |
NCT05772312 -
Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
|
||
| Recruiting |
NCT05779670 -
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
|
||
| Completed |
NCT05732558 -
Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
|
N/A | |
| Recruiting |
NCT06180525 -
Radiological Evaluation of 3D Printed Porous Collars in Hip and Knee Resection Prostheses: Pilot Study.
|
||
| Completed |
NCT04955522 -
Multimodal Imaging Analysis of Spinal Tumors
|
||
| Recruiting |
NCT05631002 -
Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
|
||
| Recruiting |
NCT06008483 -
A Dose Finding Study to Treat Bone Tumor(s)
|
Phase 1 |